HIC1 and prostate carcinoma: The results demonstrated that the addition of LY294002 in sh‐HIC1 cells inhibited the activation of the PI3K/AKT pathway induced by HIC1 knockdown, as indicated in Figure S5A, and also suppressed the growth of prostate cancer cells, shown in Figure S5C,D.